HIFU – Current evidence 55 patients with HCC Prospective, non-randomized clinical trial Tumour size 4-14cm in diameter (mean 8.14cm) Serum AFP returned to normal level in 34% of patient Overall survival rates at 6, 12 and 18 months were 86.1%, 61.5% and 35.3%, respectively Survival rates were significantly higher in patients in stage II than those in stage IIIA (p=0.0132) and in stage IIIC (p=0.0265).
{}